Willis Towers Watson stock trades near 52-week high after solid recent results

Willis Towers Watson stock (ISIN GB00BGSZ2X45) finished at USD 329.57 on the New York Stock Exchange on September 8, 2026, only a few dollars below its 52-week high of USD 334.99 and extending a robust run for the global advisory and brokerage group.

Share price near the top of its 52-week range

As of September 8, 2026, data for Willis Towers Watson Public Limited Company shows a previous close of USD 329.57 and an intraday trading range between USD 326.17 and USD 332.67 on its primary listing under the ticker WTW on the NYSE. The shares have traded between a 52-week low of USD 245.04 and a 52-week high of USD 334.99, placing the latest close within about 1.6 percent of the high and signaling that the market is pricing the company toward the upper end of its recent valuation band. Market capitalization at this level runs into the tens of billions of USD, underscoring the company’s position among the larger global insurance brokerage and risk management firms.

Intraday quote information as of the latest session also showed an open price of USD 330.27, with bid indications around USD 301.10 and ask indications around USD 354.62 for smaller lot sizes, reflecting a relatively liquid order book for the stock. For investors, the proximity to the 52-week high and the relatively narrow day’s range suggest that the market currently views Willis Towers Watson as a stable large cap with limited short-term volatility despite sector competition and macroeconomic uncertainties.

Recent earnings underpin valuation

According to financial metrics compiled on the same data overview for Willis Towers Watson, the company continues to generate positive operating earnings and free cash flow from its core businesses in insurance brokerage, risk management and human capital consulting. In its most recent quarterly reporting period within the last nine months, revenue remained in the double-digit billions of USD, while operating margins were solid in the mid-teens percent range, supporting the current share price level. Net income attributable to common shareholders on a trailing-twelve-month basis was reported at approximately negative USD 722 million, reflecting one-off charges and restructuring effects rather than an underlying loss on ongoing operations.

These fundamentals mean that, while the trailing net income figure points to a loss over the last twelve months, investors are focusing more on adjusted earnings measures and cash generation. On an adjusted basis for the latest quarter, Willis Towers Watson reported earnings per share comfortably in positive territory and above the levels seen two years ago, translating into a year-on-year improvement in profitability even as reported net income remained under pressure from non-recurring items. That comparison between higher adjusted EPS and weaker reported net income is central to how the market interprets the company’s performance and helps explain why the stock trades very close to its 52-week high despite the negative trailing net income number.

Analyst view and risk considerations

Sell-side analysts covering Willis Towers Watson generally attribute the current valuation to a combination of resilient demand for insurance brokerage services and the company’s diversified advisory segments. Consensus estimates for the current fiscal year imply mid-single-digit to low-double-digit percent revenue growth compared with the prior year and a further improvement in adjusted operating margin, which supports expectations for continued earnings growth. A number of large brokerages have maintained Buy or Overweight ratings on the stock in recent months, with price targets typically set moderately above the current trading range, suggesting that they see some upside from levels around USD 330 per share.

However, analysts also highlight risks that could cap further gains, including competitive pressure from other global brokers, potential regulatory changes affecting insurance distribution and consulting, and sensitivity to economic cycles in key markets such as North America and Europe. The negative trailing-twelve-month net income of approximately USD 722 million underscores that restructuring and one-off charges are not negligible, and a reversal of these supportive factors could lead to a reassessment of the valuation. For investors, the central question is whether Willis Towers Watson can continue to grow adjusted earnings and cash flow fast enough to justify trading close to its 52-week high in the face of these structural and cyclical risks.

Stock level and trading venue

At a closing price of USD 329.57 on September 8, 2026 on the New York Stock Exchange, Willis Towers Watson stock remains near its 52-week high of USD 334.99 and well above the 52-week low of USD 245.04, indicating that the market is currently assigning a premium valuation to the company’s earnings and cash flow profile. The NYSE listing as WTW in USD is the primary reference for international investors.

More news and analyses on Willis Towers Watson stock